Nerac

Information That Drives Innovation

We’re here to help with your research needs
+1 860 872 7000
Nerac logo Customer Access
  • Home
  • What We Do
    • Nerac IPDex™
    • Innovation Insights and Consulting Practice
    • Regulatory
    • Medical Device and Life Sciences
    • Technology Scouting and Innovation
    • Market Research
    • Intellectual Property
    • Commercialization Services for TTOs and Start-Ups
    • Critical Updates
  • Who We Serve
  • How to Engage
  • Why Nerac?
  • Meet our Team
    • Leadership Team
    • Our Analysts
    • Our Partners
  • Nerac Insights and Publications
    • Articles
    • Case Studies
    • Press Room
    • Videos
    • Webcasts
    • White Papers
  • Contact Us
You are here: Home / Nerac Insights / White Papers & Reports / Nucleic and Amino Acid Sequence Research in an Intellectual Property Management Strategy

Nucleic and Amino Acid Sequence Research in an Intellectual Property Management Strategy

Facebook0
Google+0
LinkedIn0
Twitter0

Introduction

The global market for biotechnology represents a large and complex amalgamation of different products that touches many different industry segments. In the healthcare industry alone, biologics represent a greater than $125 billion global market, and biosimilars legislation in the US and EU has spawned new generic biologics markets that will continue to grow. In addition, the even larger and more rapidly growing market for personalized medicine is driving biotechnology-based diagnostic and health management tools. In the agricultural industries, the market for genetically modified seeds and crops that are pest and disease resistant continues to grow. In the energy industries, large rounds of funding continue to drive the development of biofuels, the quality and production of which is likely to be improved by biotechnological advances. Participants in all of these markets rely on positive innovations and intellectual property (IP) rights to maintain and grow their market shares.

Want to read the rest of the article? Fill out the form to download: Nucleic and Amino Acid Sequence Research in an Intellectual Property Management Strategy
Get Download Link

 

 

 

 

Related Posts

  • IP Webinar: Patenting Best Practices
    60
    Wednesday, March 25, 2015 | 1:00 to 2:00pm (EST) Patenting Best Practices: Navigate the Patent Process Successfully! Gain a working knowledge of the patenting process and best practices. We invite you to attend a free webinar hosted by Nerac which will provide an overview of patenting best practices. This webinar will help you navigate the patenting…
    Tags: ip, property, intellectual
  • Patent Infringement – Electronics Packaging
    59
    Issue: An IP attorney for a consumer electronics company informed Nerac that they were ready to ship product and had sent samples to a retail chain and had received a concerning response. The retail chain informed the Nerac client that they were worried that the packaging might infringe on a patent that was owned by…
    Tags: ip, property, intellectual
  • Assessment of Digital Health Start-ups - Sample Research Report
    57
    By Nerac IP Analysts Originally published July 28, 2020 Changing industry demands and new business challenges are also offering unprecedented opportunity. Whether it’s sudden disruption to your supply chain, rapidly evolving market demands, disruptive technologies, new strategic partnering options or all of these things, you need the ability to pivot quickly and efficiently. You need…
    Tags: market, ip, industry, intellectual, property
  • Case Studies
  • White Papers
  • Webcasts
  • Articles
    • Nerac Strategist
    • Energy
    • Food & Nutrition
    • Intellectual Property
    • Regulatory
    • Technology & Innovation
    • Medical Device & Healthcare
    • Pharmaceutical
    • Engineering
    • Market Research
    • Critical Alerts
    • Chemistry/Advanced Materials
  • Press Room

Click here to learn more about….

3d printing advanced materials aerospace Ask Kevin Videos biotech CFDA clinical literature evaluations commercialization strategies competitive intelligence conflict minerals Disruptive Technologies energy EU MDR FDA food helga weires Industry 4.0 innovation Inspiring Next intellectual property IP market analysis market research medical device medical devices nerac Nerac client questions Nerac Strategist notified body audit open innovation patenting patenting strategies patent landscape pharmaceutical Post-Market Surveillance R&D regulatory regulatory compliance Robert Beinstein Rosemarie Szostak specialty chemicals Sustainable Development Goals technology scouting Tech Scouting XcellR8
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
  • Career Opportunities
  • Privacy Policy

Copyright © 2023 Nerac · One Technology Drive · Tolland, CT 06084 · 1.860.872.7000

Sign Up for the Nerac Strategist

Like what you see? Sign up here to receive the Nerac Strategist newsletter, a compilation of analyst insights on rapidly developing industry issues, compliance challenges and commercial opportunities!

  • This field is for validation purposes and should be left unchanged.